Method for separating carbamazepine and its related substances through liquid chromatography
一种卡马西平、液相色谱的技术,应用在液相色谱法分离卡马西平及有关物质领域,能够解决说明方法灵敏度不够、杂质E信噪比不能满足验证的条件、杂质E灵敏度低等问题
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
experiment example 1
[0104] Experimental Example 1: Verification of Chromatographic Conditions in Pharmacopoeia
[0105] According to the chromatographic conditions stipulated in the Chinese Pharmacopoeia, a system adaptability experiment was carried out on carbamazepine, and the carbamazepine sample used was produced by our company with batch number 2017021303. The specific chromatographic conditions are as follows:
[0106] (1) Chromatographic conditions
[0107]
[0108] (2) Sample preparation
[0109]
[0110]
[0111] (3) See the results figure 1 . The separation of carbamazepine and impurity A, impurity B, impurity C, impurity D and impurity E is as follows.
[0112] name
keep time
area
Number of theoretical plates
Separation
Impurity B
9.153
439898
3861
58.06
Impurity A
12.379
162994
3594
4.70
15.93
carbamazepine
14.193
8501116
3802
2.13
725.00
Impuri...
Embodiment 1
[0132] Embodiment 1: the exploratory test of carbamazepine related substance detection condition
[0133] 1. First, change the mobile phase system. There is tetrahydrofuran in the mobile phase system, which has absorption at low wavelengths, which may cover up the impurity peaks, and adopt the acetonitrile-water gradient elution method. The new chromatographic conditions are as follows:
[0134] (1) Chromatographic conditions
[0135]
[0136] (2) See the attached chromatogram for the results Figure 5 . Carbamazepine and the separation of impurities are as follows:
[0137]
[0138] (3) Conclusion
[0139] The concentration of each impurity in carbamazepine was about 9 μg / mL, one impurity in carbamazepine did not appear as a peak, and the other impurities were well separated. Reason analysis: In addition to removing tetrahydrofuran from the mobile phase, triethylamine was removed at the same time, and the impurity of carbamazepine contains N, so there is no peak. ...
Embodiment 2
[0200] Embodiment 2 Destructive test
[0201] 1 Acid, alkali and oxidation damage (sample group: 2017032801)
[0202] 1.1 Undestroyed API
[0203] Take 75 mg of carbamazepine raw material, accurately weigh it, put it in a 50 ml measuring bottle, add 25 ml of methanol to dissolve, ultrasonically dissolve, add water to dilute to the mark, shake well, and obtain. Measure 5.00ml of the solution in a 50ml volumetric flask, add 22ml of methanol, dilute with water to the mark, and shake well to obtain.
[0204] see attached results Figure 17 :
[0205] name
keep time
peak name
Purity angle
Purity Threshold
area
area%
Separation
s / n
1
21.338
main peak
0.232
0.345
52876503
100
12862.92
[0206] 1.2 Acid Destruction
[0207] Acid-base blank: Pipette 5.00ml of 1mol / L hydrochloric acid solution and sodium hydroxide solution into a 50ml volumetric flask, add 25ml of methanol solution, dilute with water to t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap